We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 12,168

Endo Pharmaceuticals Solutions v. Custopharm Inc.
  • Knobbe Martens
  • USA
  • July 16 2018

A prior art reference does not inherently disclose the elements of a claim limitation if the prior art describes the performance of the elements but


Jazz Pharmaceuticals, Inc. v. Amneal Pharmaceuticals, LLC
  • Knobbe Martens
  • USA
  • July 16 2018

References were sufficiently accessible to the public to constitute printed publication prior art even if they were not searchable or indexed because


House Opioid Measure Frenzy Continues
  • Quarles & Brady LLP
  • USA
  • July 16 2018

Over a period of two weeks in June, the House passed several bills aimed at combating the ongoing opioid epidemic. Our summary of the earlier measures


The Smoke Hasn’t Cleared: What’s the Workplace Impact of the FDA’s Approval of a Marijuana Based Drug?
  • Shawe Rosenthal LLP
  • USA
  • July 13 2018

The FDA recently approved Epidiolex (cannabidiol), which contains a marijuana-derived drug substance, for the treatment of two rare forms of epilepsy


In the Weeds: Navigating the Shifting Federal Regulation of Medical Marijuana
  • K&L Gates
  • USA
  • July 13 2018

The federal government’s view of medical marijuana is evolving as the U.S. Food and Drug Administration (“FDA” or “Agency”), on June 25, 2018


FDA Publishes Proposed Revision to and Extended Compliance Date for Front of Pack Calorie Declaration for Vending Machines
  • Keller and Heckman LLP
  • USA
  • July 13 2018

The Food, Drug, and Cosmetic Act (FDCA) Section 403(q)(5)(H) (located at 21 USC Section 343(q)(5)(H)) requires certain vending machine operators to


USDA and FDA Initiate Processes to Revise Regulation of Agricultural Biotechnology
  • Arent Fox LLP
  • USA
  • July 13 2018

The United States Department of Agriculture and the Food and Drug Administration have recently initiated processes to evaluate and propose revisions


The FDA Approves Active Ingredient Derived from Marijuana to Treat Epilepsy
  • Knobbe Martens
  • USA
  • July 13 2018

On June 25th, 2018, the U.S. Food and Drug Administration (FDA) approved the drug, Epidiolex, for the treatment of seizures associated with two rare


FDA Issues Proposed Rule on Front-of-Pack Calorie Disclosures Used for Vending Machine Labeling Compliance
  • Hogan Lovells
  • USA
  • July 13 2018

The Food and Drug Administration (FDA) is proposing to revise the type size requirements for front-of-pack (FOP) calorie declarations that are used to


Takeaways from FDA ‘Steak-holder’ Meeting on Cell-Cultured Foods
  • Morgan Lewis & Bockius LLP
  • USA
  • July 13 2018

The Food and Drug Administration (FDA) held a public meeting July 12 on “Foods Produced Using Animal Cell Culture Technology” to give the public an